Malignant tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Confirmed as malignant solid tumor by imaging and pathological examinations; 2. Aged 18-75 years old; 3. Receiving treatment in our hospital; 4. Expected survival period > 6 months; 5. No contraindications to anti-tumor treatment; 6. Complete clinical data; 7. Signed the informed consent form, voluntarily participated in this study, with good compliance and available for follow-up.
Exclusion criteria
Exclusion criteria: 1. Abnormal communication or hearing function, unable to cooperate with dietary intervention; 2. Daily physical performance with a Karnofsky Performance Scale (KPS) score <= 60; 3. Complicated with metabolic disorders or coagulation disorders; 4. Complicated with dysfunction of major organs such as the heart, liver, lungs, and kidneys; 5. Complicated with autoimmune diseases or infectious diseases; 6. Patients with alcoholism, drug addiction, or those who are pregnant or lactating; 7. Patients who refuse to sign or fail to understand the informed consent form; 8. Patients who withdraw from the study midway; 9. Patients who are unable to complete the study for any other reasons, as judged by the researchers; 10. Patients with daily dietary intake < 800 kcal for more than 5 days during the intervention period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indicators of the body's inflammatory response;Incidence rate of adverse reactions in tumor treatment;Comprehensive Score of Nutritional Status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's quality of life;Objective Response Rate (ORR) of tumors; | — |
Countries
China
Contacts
The Second Affiliated Hospital Of Zhengzhou University